MAP3K14 and metabolic dysfunction-associated steatotic liver disease: These data suggest that aberrant activation of hepatic NIK suppresses hepatocyte proliferation and liver regeneration in NAFLD at least in part by inhibiting the JAK2/STAT3 pathway.